All-trans retinoic acid as adjunct to intensive treatment in younger adult patients with acute myeloid leukemia: results of the randomized AMLSG 07-04 study Richard F. SchlenkMichael Lübbertfor the German-Austrian Acute Myeloid Leukemia Study Group Original Article Open access 03 October 2016 Pages: 1931 - 1942
Familial hematological malignancies: new IDH2 mutation Walid-Sabri HamadouViolaine BourdonZohra Soua Original Article 03 September 2016 Pages: 1943 - 1947
CD34 expression and the outcome of nucleophosmin 1-mutated acute myeloid leukemia Jordi JuncàOlga GarciaFuensanta Millá Original Article 05 September 2016 Pages: 1949 - 1954
Emerging resistant bacteria strains in bloodstream infections of acute leukaemia patients: results of a prospective study by the Rete Ematologica Lombarda (Rel) Chiara CattaneoP. ZappasodiG. Rossi Original Article 21 September 2016 Pages: 1955 - 1963
CD18 promoter methylation is associated with a higher risk of thrombotic complications in primary myelofibrosis Claudia AugelloDaniele CattaneoUmberto Gianelli Original Article 05 September 2016 Pages: 1965 - 1969
Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation: a retrospective study of the MDS subcommittee of the CMWP of the EBMT E. M. P. CremersA. van BiezenT. de Witte Original Article Open access 20 September 2016 Pages: 1971 - 1978
BCR and chemokine responses upon anti-IgM and anti-IgD stimulation in chronic lymphocytic leukaemia Andrea HaerzschelJulie CatusseMeike Burger Original Article Open access 20 August 2016 Pages: 1979 - 1988
Individual differences in physical symptom burden and psychological responses in individuals with chronic lymphocytic leukemia Eleshia J. MorrisonJoseph M. FlynnBarbara L. Andersen Original Article 19 August 2016 Pages: 1989 - 1997
Detection of the value of consecutive serum total light chain (sTLC) in patients diagnosed with diffuse large B cell lymphoma Linzhu ZhaiYuanyuan ZhaoLizhu Lin Original Article 14 September 2016 Pages: 1999 - 2007
Hypoalbuminemia is significantly associated with increased clearance time of high dose methotrexate in patients being treated for lymphoma or leukemia Samantha N. ReissLarry W. BuieDan Douer Original Article 20 August 2016 Pages: 2009 - 2015
Influence of the watch and wait strategy on clinical outcomes of patients with follicular lymphoma in the rituximab era Sayako YudaDai MaruyamaKensei Tobinai Original Article Open access 26 September 2016 Pages: 2017 - 2022
Clinical features and survival of extranodal natural killer/T cell lymphoma with and without hemophagocytic syndrome Jing JiaYuqin SongJun Zhu Original Article 06 September 2016 Pages: 2023 - 2031
Outcomes with two different schedules of bortezomib, melphalan, and prednisone (VMP) for previously untreated multiple myeloma: matched pair analysis using long-term follow-up data from the phase 3 VISTA and PETHEMA/GEM05 trials Maria-Victoria MateosAlbert OriolJesus San Miguel Original Article 14 October 2016 Pages: 2033 - 2041
The impact of H63D HFE gene carriage on hemoglobin and iron status in children Kaczorowska-Hac BarbaraLuszczyk MarcinKaczor Jan Jacek Original Article Open access 24 August 2016 Pages: 2043 - 2048
The impact of postpartum hemoglobin levels on maternal quality of life after delivery: a prospective exploratory study C. M. MillerB. RamachandranAlexander J. Butwick Original Article 13 September 2016 Pages: 2049 - 2055
Incidence of catheter-related thrombosis in acute leukemia patients: a comparative, retrospective study of the safety of peripherally inserted vs. centrally inserted central venous catheters Mohammad RefaeiBruna FernandesCynthia Wu Original Article 20 August 2016 Pages: 2057 - 2064
How can we help haematological cancer survivors cope with the changes they experience as a result of their cancer? Alix HallMarita LynaghJamie Bryant Original Article 13 September 2016 Pages: 2065 - 2076
Improvement in hereditary hemorrhagic telangiectasia after treatment with the multi-kinase inhibitor Sunitinib Freya DroegeKruthika ThangaveluUrban Geisthoff Letter to the Editor 15 August 2016 Pages: 2077 - 2078
Isolated thrombocytopenia and liver function abnormalities characterizing an atypical presentation of thrombotic thrombocytopenic purpura Rajat BansalMaria R. BaerJennie Y. Law Letter to the Editor 20 August 2016 Pages: 2079 - 2080
Acute monocytic leukemia masked by hemolytic anemia and sclerotic lesions Michael Sze Yuan LowShahla VilcassimGeorge Grigoriadis Letter to the Editor 30 August 2016 Pages: 2081 - 2082
End-of-treatment FDG-PET lacks usefulness in Hodgkin lymphoma Hugo J. A. AdamsThomas C. Kwee Letter to the Editor 03 September 2016 Pages: 2083 - 2084
No convincing evidence to support postinduction FDG-PET in follicular lymphoma Hugo J. A. AdamsThomas C. Kwee Letter to the Editor 08 September 2016 Pages: 2085 - 2086
Therapeutic drug monitoring enables safe and effective lenalidomide therapy in patients with multiple myeloma on hemodialysis Takahiro KobayashiTakenori NiiokaNaoto Takahashi Letter to the Editor 06 September 2016 Pages: 2087 - 2088
Effects of low-dose thalidomide in chronic refractory immune thrombocytopenia and contributions to the dispensation of glucocorticoid dependence Yafei YinMingyang DengGuangsen Zhang Letter to the Editor 03 September 2016 Pages: 2089 - 2090
Acquired protein S deficiency manifests as pulmonary embolism in early pregnancy: a case report Kristina GvozdjanRuth JuodikisVladimir Vidanovic Letter to the Editor 06 September 2016 Pages: 2091 - 2092
Attempted suicide with rivaroxaban Dorit BlicksteinSaaid YounesSigal Nakav Letter to the Editor 14 September 2016 Pages: 2093 - 2094
Linezolid-associated reticulocytopenia Danielle H. OhOlga MotornaMichael Gilbertson Letter to the Editor 23 September 2016 Pages: 2095 - 2097
Acquired hemophilia A in a patient with hepatocellular carcinoma: a case report and literature review A. I. Franco-MorenoM. Santero-GarcíaM. J. García-Navarro Letter to the Editor 26 September 2016 Pages: 2099 - 2100
CALR-mutated primary myelofibrosis evolving to chronic myeloid leukemia with both CALR mutation and BCR-ABL1 fusion gene Joana Maria Saraiva DiamondAntónio Medina de AlmeidaManuel Maria de Sousa Ferreira Abecasis Letter to the Editor 03 October 2016 Pages: 2101 - 2104
Re: Prognostic value of CALR vs. JAK2V617F mutations on splenomegaly, leukemic transformation, thrombosis, and overall survival in patients with primary fibrosis: a meta-analysis Hampig Raphael KourieLieveke AmeyeDominique Bron Letter to the Editor 29 September 2016 Pages: 2105 - 2106